Selected article for: "SD standard deviation and standard deviation"
Author: Park, Jinsung; Shin, Dong Wook; Kim, Tae-Hwan; Jung, Seung Il; Nam, Jong Kil; Park, Seung Chol; Hong, Sungwoo; Jung, Jae Hung; Kim, Hongwook; Kim, Won Tae
Title: Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24
  • Document date: 2017_3_10
    • ID: 4pbwjlm3_18
    Snippet: Between November 2014 and December 2015, 291 patients were screened. After excluding patients with exclusion criteria, 249 (mean age, 66.7 years; standard deviation, 13.0) were enrolled into the study. Baseline sociodemographic and clinical characteristics are shown in Table 1 . Majority of patients SD, standard deviation; PUNLMP, papillary urothelial neoplasm of low malignant potential; TURBT, transurethral resection of bladder tumor. and 145 (5.....
    Document: Between November 2014 and December 2015, 291 patients were screened. After excluding patients with exclusion criteria, 249 (mean age, 66.7 years; standard deviation, 13.0) were enrolled into the study. Baseline sociodemographic and clinical characteristics are shown in Table 1 . Majority of patients SD, standard deviation; PUNLMP, papillary urothelial neoplasm of low malignant potential; TURBT, transurethral resection of bladder tumor. and 145 (58.2%), the third. At the second and third visit, main reason for not completing the questionnaires was administrative failure (57 and 66 cases, respectively), while other reasons included follow-up loss (nine and 20 cases, respectively), patient refusal (10 and 15 cases, respectively) and progression to muscle-invasive BC (one and three cases, respectively).

    Search related documents:
    Co phrase search for related documents
    • administrative failure and patient refusal: 1
    • bladder tumor and low malignant potential: 1
    • bladder tumor and malignant potential: 1
    • bladder tumor and mean age: 1
    • bladder tumor and transurethral resection: 1, 2, 3, 4, 5, 6, 7
    • bladder tumor transurethral resection and transurethral resection: 1, 2, 3, 4, 5, 6
    • exclusion criterion and mean age: 1
    • follow loss and mean age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • follow loss and patient refusal: 1
    • follow loss and standard deviation: 1
    • follow loss and study enrol: 1
    • low malignant potential and malignant potential: 1, 2, 3, 4, 5, 6
    • low malignant potential and mean age: 1